HIV Treatment Breakthrough: Gilead and Merck (MSD) will present Phase 3 results for an investigational once-weekly oral HIV regimen combining islatravir and lenacapavir, showing maintained virological suppression after switching from daily therapy. Pharma Ad Wars: Novo Nordisk sues Eli Lilly in the US over “false and misleading” GLP-1 weight-loss and diabetes ads, alleging outdated dose comparisons and missing clinical context. UK Tech Governance Shake-up: Andy Burnham appoints the UK’s first Cabinet-level AI minister and dissolves DSIT, reshuffling oversight for data centers, procurement, copyright, and semiconductors. AI in Travel & Hospitality: DirectBooking and DeepYou form a JV to build China’s agent-to-agent AI direct-booking platform, with robotic staff and assistant services. Wildfire Risk Modeling: KatRisk and Technosylva launch next-gen wildfire capabilities that move beyond static hazard maps using physics-based fire behavior. Space & Research Infrastructure: CERN’s Large Hadron Collider enters a long shutdown for the High-Luminosity upgrade, aiming for a major data boost around 2030. Biotech Innovation: UC San Diego and Rady Children’s report gene-therapy results for SCN2A-related childhood epilepsy in personalized trials, with big seizure reductions. Cyber/Finance: Uphold launches crypto-to-equities trading for 4,000+ US stocks and ETFs in one app. Public Health Watch: The cyclospora outbreak response continues as US case counts rise and FDA traceback work focuses on specific lettuce supply chains. Industrial Tech: FDH Aero and GKN Aerospace sign a long-term supply agreement at Farnborough to streamline aerospace manufacturing.